The pharmaceutical community is intrigued by retatrutide, a innovative dual GIP and GLP-1 receptor that’s showing remarkable results in early trials . This compound works by imitating natural hormones to regulate appetite and boost feelings of satiety, ultimately contributing to noticeable body decrease. While currently under investigation and no